(Q36198607)

12 August 2017

1 reference

title

Dendritic cell-based immunotherapy for malignant gliomas (English)

1 reference

12 August 2017

1 reference

1 reference

Yasuharu Akasaki

1

1 reference

PubMed ID

16026233

12 August 2017

Keith L Black

series ordinal

2

1 reference

PubMed ID

16026233

12 August 2017

John S Yu

series ordinal

3

1 reference

12 August 2017

1 July 2005

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

12 August 2017

1 reference

12 August 2017

5

1 reference

12 August 2017

497-508

1 reference

12 August 2017

4

1 reference

Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality.

12 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Brain tumor survival: results from the National Cancer Data Base

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Treatment of intracranial glioma with in situ interferon-gamma and tumor necrosis factor-alpha gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Leukocyte traffic in the central nervous system: the participants and their roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Immunotherapeutic approaches in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Microglia induce CD4 T lymphocyte final effector function and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Brain-derived gangliosides induce cell cycle arrest in a murine T cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Microglia in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Cytokines and immunoregulatory molecules in malignant glial neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Brain dendritic cells and macrophages/microglia in central nervous system inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Dendritic cells and tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

21 January 2018

CNS antigen presentation

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Intratumoral dendritic cell vaccination elicits potent tumoricidal immunity against malignant glioma in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Intratumoral injection of dendritic and irradiated glioma cells induces anti-tumor effects in a mouse brain tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Expression of the tumor-rejection antigen SART1 in brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Expression of the SART3 tumor-rejection antigen in brain tumors and induction of cytotoxic T lymphocytes by its peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Recognition of ADP-ribosylation factor 4-like by HLA-A2-restricted and tumor-reactive cytotoxic T lymphocytes from patients with brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

UDP-Gal: betaGlcNAc beta1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumour antigen recognised by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

AIM-2: a novel tumor antigen is expressed and presented by human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Does the immune system see tumors as foreign or self?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Acquired immune deficiency syndrome (AIDS) and cerebral astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Glioblastoma multiforme of the brain stem in a patient with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Glioblastoma in kidney transplant recipients. Report of five cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Modulation of T-cell function by gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Effects of glioma cells on maturation of dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Type 1 T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

The induction of tolerance by dendritic cells that have captured apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Tolerogenic dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Immature, but not inactive: the tolerogenic function of immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Properties and regulation of cytosolic phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Immune defects observed in patients with primary malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Cancer vaccines and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Cytokine gene therapy for malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Dendritic cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Induction of effective antitumor immunity in a mouse brain tumor model using B7-1 (CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Administration of interleukin-12 and -18 enhancing the antitumor immunity of genetically modified dendritic cells that had been pulsed with Semliki forest virus-mediated tumor complementary DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Vaccination with tumor cell lysate-pulsed dendritic cells augments the effect of IFN-beta gene therapy for malignant glioma in an experimental mouse intracranial glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

The central role of CD4(+) T cells in the antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Help for cytotoxic-T-cell responses is mediated by CD40 signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Interleukin-18 regulates both Th1 and Th2 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

A unique role for IL-23 in promoting cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Small interference RNA modulation of IL-10 in human monocyte-derived dendritic cells enhances the Th1 response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.497

21 January 2018

Identifiers

DOI

10.1586/14737175.5.4.497

1 reference

12 August 2017

1 reference

PubMed ID

16026233